CorMedix Inc Stock Prediction and Forecast [CRMD]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 21 Oct 2025, 04:09 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for CorMedix Inc Stock Prediction and Forecast [CRMD]](https://i.ytimg.com/vi/p3YgxqQhxD0/hqdefault.jpg)
AI-generated source summary
CorMedix (CRMD) stock is analyzed with a focus on its potential as a buy. The analysis begins with a system identification of CRMD as a buy candidate, scoring 4.38 as of October 20, 2025. Short-term, CRMD is in a broad, declining trend with a potential 6.73% decline over three months and returns between -22.93% and +9.43%. Longer-term the 12-month analysis projects a 17.61% change, returns between -29.53% and +68.58%. On the last trading day the price closed at $12.16, which is a rise of 19.45% on the last trading day. The low/high for this day was $11.22 and $12.56, and had fluctuations of 11.97%. Based on the last 100 insider trades we have determined an insider power with ratio of 24.844. A stop loss is advised at $11.69.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.